Patents by Inventor David G. Simpson

David G. Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9399082
    Abstract: The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: July 26, 2016
    Assignees: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Virginia Commonwealth University
    Inventors: Gary L. Bowlin, David G. Simpson, James R. Bowman, Stephen W. Rothwell
  • Patent number: 8586345
    Abstract: The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: November 19, 2013
    Assignee: Virginia Commonwealth University Intellectual Property Foundation
    Inventors: David G. Simpson, Gary L. Bowlin, Gary E. Wnek, Peter J. Stevens, Marcus E. Carr, Jamil A. Matthews, Saravanamoorthy Rajendran
  • Publication number: 20130178949
    Abstract: Electrospun materials are fabricated using air-flow impedance technology, which results in the production of scaffolds in which some regions are dense with low porosity and others regions are less dense and more porous. The dense regions provide structural support for the scaffold while the porous regions permit entry of cells and other materials into the scaffold, e.g. when used for tissue engineering.
    Type: Application
    Filed: June 28, 2011
    Publication date: July 11, 2013
    Applicant: Virginia Commonwealth University
    Inventors: Gary L. Bowlin, Michael J. McClure, David G. Simpson, Hu Yang
  • Publication number: 20110288026
    Abstract: The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.
    Type: Application
    Filed: March 21, 2011
    Publication date: November 24, 2011
    Inventors: David G. Simpson, Gary L. Bowlin, Gary E. Wnek, Peter J. Stevens, Marcus E. Carr, Jamil A. Matthews, Saravanamoorthy Rajendran
  • Publication number: 20110280841
    Abstract: The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
    Type: Application
    Filed: January 18, 2011
    Publication date: November 17, 2011
    Applicant: Virginia Commonwealth University Intellectual Property Foundation
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson
  • Publication number: 20110150973
    Abstract: The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen.
    Type: Application
    Filed: April 10, 2009
    Publication date: June 23, 2011
    Inventors: Gary L. Bowlin, David G. Simpson, James R. Bowman, Stephen W. Rothwell
  • Publication number: 20100310658
    Abstract: The invention is directed to formation and use of electroprocessed fibrin as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed fibrin may also be combined with other molecules in order to deliver the molecules to the site of application or implantation of the electroprocessed fibrin. The fibrin or fibrin/cell suspension is electrodeposited onto a substrite to form the tissues and organs.
    Type: Application
    Filed: June 8, 2010
    Publication date: December 9, 2010
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson, Philippe Lam, Marcus E. Carr, JR.
  • Publication number: 20100291058
    Abstract: The present invention relates to sealants for skin and other tissues. The sealants include an electroprocessed material. The sealants may contain more than one electroprocessed materials and may contain additional substances. The invention further relates to methods of making and using such sealants.
    Type: Application
    Filed: April 12, 2010
    Publication date: November 18, 2010
    Applicants: Virginia Commonwealth University, Nanomatrix, Inc.
    Inventors: Gary L. Bowlin, David G. Simpson, Gary E. Wnek, Marcus E. Carr, JR., Peter J. Stevens, Gary Cadd, I. Kelman Cohen
  • Patent number: 7759082
    Abstract: The invention is directed to formation and use of electroprocessed fibrin as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed fibrin may also be combined with other molecules in order to deliver the molecules to the site of application or implantation of the electroprocessed fibrin. The fibrin or fibrin/cell suspension is electrodeposited onto a substrate to form the tissues and organs.
    Type: Grant
    Filed: January 26, 2004
    Date of Patent: July 20, 2010
    Assignee: Virginia Commonwealth University Intellectual Property Foundation
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson, Philippe Lam, Marcus E. Carr, Jr.
  • Patent number: 7615373
    Abstract: The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: November 10, 2009
    Assignees: Virginia Commonwealth University Intellectual Property Foundation, Organogenesis, Inc.
    Inventors: David G. Simpson, Gary L. Bowlin, Gary E. Wnek, Peter J. Stevens, Marcus E. Carr, Jamil A. Matthews, Saravanamoorthy Rajendran
  • Publication number: 20080159985
    Abstract: The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 3, 2008
    Applicant: Virginia Commonwealth University Intellectual Property Foundation
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson
  • Patent number: 7374774
    Abstract: The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
    Type: Grant
    Filed: September 22, 2003
    Date of Patent: May 20, 2008
    Assignee: Virginia Commonwealth University Intellectual Property Foundation
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson
  • Publication number: 20040229333
    Abstract: The invention is directed to formation and use of electroprocessed fibrin as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed fibrin may also be combined with other molecules in order to deliver the molecules to the site of application or implantation of the electroprocessed fibrin. The fibrin or fibrin/cell suspension is electrodeposited onto a substrate to form the tissues and organs.
    Type: Application
    Filed: January 26, 2004
    Publication date: November 18, 2004
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson, Philippe Lam, Marcus E. Carr
  • Patent number: 6787357
    Abstract: The invention is directed to use of fibrin as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or “organ-like” tissue. A preferred embodiment is a plasma-derived fibrin matrix containing cells.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: September 7, 2004
    Assignee: Virginia Commonwealth University
    Inventors: Gary L. Bowlin, Gary Wnek, David G. Simpson, Philippe Lam, Marcus E. Carr, Helen Fillmore
  • Publication number: 20040116032
    Abstract: A matrix of collagen is obtained through the method of electroprocessing. As a common natural polymer, collagen may be electroprocessed to form a matrix for multiple different applications.. The flexibility and variability of the processing allows the collagen matrix to be predesigned to meet many applications. These applications are included, but not limited to, biomedical applications, manufactured leather applications, food casing products, and footwear and clothing products.
    Type: Application
    Filed: July 29, 2003
    Publication date: June 17, 2004
    Inventors: Gary L. Bowlin, Gary Wnek, David G. Simpson
  • Publication number: 20040058887
    Abstract: The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 25, 2004
    Inventors: Gary L. Bowlin, Gary E. Wnek, David G. Simpson
  • Publication number: 20040037813
    Abstract: The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.
    Type: Application
    Filed: May 28, 2003
    Publication date: February 26, 2004
    Inventors: David G. Simpson, Gary L. Bowlin, Gary E. Wnek, Peter J. Stevens, Marcus E. Carr, Jamil A. Matthews, Saravanamoorthy Rajendran
  • Publication number: 20040018226
    Abstract: The invention is directed to novel compositions comprising an electroprocessed material and a substance, their formation and use. The electroprocessed material can, for example, be one or more natural materials, one or more synthetic materials, or a combination thereof. The substance can be one or more therapeutic or cosmetic substances or other compounds, molecules, cells, vesicles. The compositions can be used in substance delivery, including drug delivery within an organism by, for example, releasing substances or containing cells that release substances. The compositions can be used for other purposes, such as prostheses or similar implants.
    Type: Application
    Filed: April 7, 2003
    Publication date: January 29, 2004
    Inventors: Gary E. Wnek, David G. Simpson, Gary L. Bowlin, Li Yao, El-Rafaie Kenawy, John M. Layman, Elliott H. Sanders, John Fenn
  • Publication number: 20040009600
    Abstract: A muscle implant includes an extracellular matrix, tendon and muscle cells. The extracellular matrix is made of a matrix of electroaerosol polymer droplets. Cardiac and smooth muscles may be formed by depositing an extracellular matrix onto a mandrel, the extracellular matrix comprising a polymer helically wound around the mandrel at predetermined pitches.
    Type: Application
    Filed: April 22, 2003
    Publication date: January 15, 2004
    Inventors: Gary L. Bowlin, Gary Wnek, David G. Simpson
  • Publication number: 20030207638
    Abstract: Electroprocessed polymers are used to form specifically-shaped shoes, clothing or other related garments. A mandrel having a preselected shape is used as the target in the electroprocessing step. The resulting product has a polymer matrix of exactly the shape of the mandrel. In practice, a person's foot or other body part is used to create the predetermined shape.
    Type: Application
    Filed: April 7, 2003
    Publication date: November 6, 2003
    Inventors: Gary L. Bowlin, David G. Simpson, Gary Wnek